Page 36 - Human Longevity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Precision Medicine Software Market Worth $2.55 billion by 2028 - Exclusive Report by Meticulous Research "Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028," published by Meticulous Research , the precision medicine software market is expected to grow at a CAGR of 11.2% from 2021 to reach $2.55 billion by 2028. Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5011 For many years, ...

Edifice Health, a San Mateo, CA-based immunological health and personalized nutrition company, raised $12m in funding. The round was led by Leaps by Bayer with participation from Paladin Capital Group, Vertical Venture Partners, Ahren Innovation Capital, Ataraxia Capital Partners, Shanda Grab Ventures, Alafi Capital, and Taisho Pharmaceutical. Seed stage investors include Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital GmbH, and Better Food Ventures. Leaps by Bayer’s Naveen Krishnan, MD, MPhil, a...

MedCity News Serimmune CEO: Leveraging the functional antibody repertoire will transform healthcare In response to emailed questions, the CEO and CTO talk about the immune intelligence startups' Human Immunity Map -- a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics. Shares0 Serimmune CEO Noah Nasser and CTO John Shon discussed the capabilities of the immune intelligence startup intended to aid in the development of diagnostics, vaccines, and therapeutics. What is Serimmune? Serimmune is an immune intelligence comp...

Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging News provided by Share this article Share this article SAN MATEO, Calif., April 22, 2021 /PRNewswire/ -- Edifice Health, a Silicon Valley emerging company in immunological health and personalized nutrition, today announced a $12 Million investment, led by Leaps by Bayer. Through its highly-differentiated approach, Edifice aims to harness previously unattainable insights into the root causes of chronic diseases of aging, followed by delivering hig...

NIH aims to address COVID testing disparities in underserved communities NIH aims to address COVID testing disparities in underserved communities Kelsy Ketchum, 360Dx Print Not long after the start of COVID-19 pandemic, communities of color as well as underserved communities, in general, complained about their lack of access to testing. More than a year later, some diagnostic companies say they are seeing a decline in COVID-19 testing as more tests are being made available. Yet for those in neighborhoods where access to tests were limited, challenges to getting a SARS-CoV-2 test remains. To ...